|drug3500||Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14 Wiki||1.00|
|drug3513||Two doses of pilot scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14 in elderly Wiki||1.00|
|drug3512||Two doses of pilot scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14 Wiki||1.00|
There is one clinical trial.
This is a randomized controlled trial of isolated patients with diabetes admitted to Nordsjællands Hospital with or without COVID-19-pneumonia. A continuous glucose monitoring (CGM) based system with transmission of glucose data to a central system is used for remote monitoring of glucose levels and compared to standard finger-prick glucose. Blinded (to patients) CGM is mounted in the finger-prick group.
Description: TIR is presented in percent of time in which the participants' glucose values are in different glucose ranges.Measure: Time In Range (TIR) for blood glucose Time: 1-2 weeks
Description: Saved patient-personnel contacts related to blood glucose measurements, incl. time healthcare providers spent on diabetes related tasks and PPE related tasks, during the patients' hospitalization.Measure: Saved patient-personnel contacts related to blood glucose measurements. Time: 1-2 weeks
Description: Additional glucose outcomes based on data from Dexcom G6 are for example Time Above Range (TAR), Time Below Range (TBR), average glucose, variance in glucose (CV), etc.Measure: Glucose variations during hospitalization Time: 1-2 weeks
Description: That is: Tablet-based and insulin-based regimens and number of times that sliding scale insulin (including dose of insulin) has been administered for each patient.Measure: Blood glucose lowering interventions Time: 1-2 weeks
Description: Number of techincal errors during the sensors lifetime.Measure: CGM sensor performance Time: 1-2 weeks
Description: Hospital death (yes/no), length of stay at hospital, need for respiratory support (yes/no) and intensive care (yes/no), recovered vs. fatal (death within 60 days from admission).Measure: Course of hospital stay. Time: 1-2 weeks
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports